A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...
There is an urgency to getting screened," says an expert gastroenterologist. See what the recent guideline changes mean for you.
Colton said that he has seen patients miss the symptoms of colorectal cancer "far too often." Many patients, especially younger ones, "brush off" the warning signs, he said. He said that any lasting, ...
The American Cancer Society updated its colorectal cancer screening guidelines to reflect advances in technology and increase access to screening.
Most people are waiting for something dramatic — a sharp pain, a visible lump, something unmistakable. But the reality, ...
A former Ipswich Town chairman has encouraged people not to ignore the warning signs of bowel cancer after he was recently ...
Abbott (NYSE: ABT) today announced that the American Cancer Society (ACS) has released updated colorectal cancer (CRC) screening guidelines that reaffirm Cologuard® and Cologuard Plus® as preferred ...
The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results